Boston firms pay $33M for Northborough Genzyme site
The site of a Northborough operations center for the biotech firm Genzyme has been bought by two Boston firms for $33 million. Boston's Camber Development and real estate investment firm Wheelock Street Capital, which has offices in Boston and Greenwich, Conn., bought the site in a deal closed Feb. 17. The seller was the Chicago real estate investment firm Capri EGM. The deal was announced by the Boston offices of JLL Capital Markets, which represented the buyers. Camber and Wheelock Street Capital didn't return messages seeking comment. The 19-acre site at 11 Forbes Road includes a building ...